JSH BIOTECH ApS: Financial statements 2019
CVR: 25220129
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
JSH BIOTECH ApS (CVR 25220129) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 265,775 and a net result of DKK 438,248 compared with DKK 33,578 the year before. Equity in the 2019 report amounted to DKK 992,039. The solvency ratio was 51.3%.
- Gross Profit
- DKK 265,775
- Profit/Loss
- DKK 438,248
- Equity
- DKK 992,039
- Total Assets
- DKK 1,933,001
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 266 t. | 438 t. | 992 t. | - |
| 2018 | - | -14 t. | 34 t. | 554 t. | - |
| 2017 | - | -8 t. | -25 t. | 520 t. | - |
| 2016 | - | -7 t. | -27 t. | 546 t. | - |
| 2015 | - | -17 t. | 77 t. | 573 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
JSH BIOTECH ApS has published its annual report for 2018. Gross profit came to DKK -14,011, and the net result was DKK 33,578.
About JSH BIOTECH ApS
JSH BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named VICH 5941 ApS. The management consists of John Sørensen Haurum. The company is owned by John Sørensen Haurum. In 2025, the company reported a gross profit of DKK 620,332 and a net result of DKK 3,409,861 compared with DKK 1,154,367 the year before. Equity in the 2025 report amounted to DKK 6,651,503.